Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting neddylation E2s: a novel therapeutic strategy in cancer
Yi‐Chao Zheng, Yan-Jia Guo, Bo Wang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Protein neddylation and its role in health and diseases
Shizhen Zhang, Qing Yu, Zhijian Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 35
Combination Therapy and Dual-Target Inhibitors Based on LSD1: New Emerging Tools in Cancer Therapy
Liang Shen, Bo Wang, ShaoPeng Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 922-951
Closed Access | Times Cited: 16
Neddylation suppression by a macrophage membrane-coated nanoparticle promotes dual immunomodulatory repair of diabetic wounds
Ruiyin Zeng, Bin Lv, Ze Lin, et al.
Bioactive Materials (2024) Vol. 34, pp. 366-380
Open Access | Times Cited: 15
Cofilin and Actin Dynamics: Multiple Modes of Regulation and Their Impacts in Neuronal Development and Degeneration
James R. Bamburg, Laurie S. Minamide, O’Neil Wiggan, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2726-2726
Open Access | Times Cited: 79
The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy
Yunkai Yang, Min Zhang, Yan Wang
Journal of the National Cancer Center (2022) Vol. 2, Iss. 4, pp. 277-290
Open Access | Times Cited: 58
Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions
Dong‐Jun Fu, Ting Wang
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 24
An adaptive stress response that confers cellular resilience to decreased ubiquitination
Liam C. Hunt, Vishwajeeth Pagala, Anna Stephan, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways
Dequan Liu, Xiangyu Che, Guangzhen Wu
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 10
A small molecule inhibitor of the UBE2F-CRL5 axis induces apoptosis and radiosensitization in lung cancer
Tiantian Xu, Qisheng Ma, Yanan Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 31
Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy
Xian-Miao Li, Zhenyu Zhao, Yu Xiao, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Neddylation activated TRIM25 desensitizes triple-negative breast cancer to paclitaxel via TFEB-mediated autophagy
Bowen Zheng, Fengyuan Qian, Xuehui Wang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 5
CUL1-neddylation contributes to K29-linked ubiquitination on p27 for autophagic degradation in sorafenib-resistant liver cancer
Haitao Xu, Shaoyue Zheng, Qiuqi Zhang, et al.
Cell Biology and Toxicology (2025) Vol. 41, Iss. 1
Open Access
Neddylation and MASLD: From Pathophysiology to Therapy
Wenjun Lin, Wenfang Zheng, Ning Dai, et al.
Liver International (2025) Vol. 45, Iss. 5
Closed Access
SUMOylation and DeSUMOylation: Prospective therapeutic targets in cancer
Wenyan Wu, Chao Huang
Life Sciences (2023) Vol. 332, pp. 122085-122085
Closed Access | Times Cited: 12
Targeting cullin neddylation for cancer and fibrotic diseases
Zhangxu He, Wei-guang Yang, Dan Zengyangzong, et al.
Theranostics (2023) Vol. 13, Iss. 14, pp. 5017-5056
Open Access | Times Cited: 12
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma
Iris C. Salaroglio, Dimas Carolina Belisario, Paolo Bironzo, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 17
Evaluating the Role of Neddylation Modifications in Kidney Renal Clear Cell Carcinoma: An Integrated Approach Using Bioinformatics, MLN4924 Dosing Experiments, and RNA Sequencing
Dequan Liu, Guangzhen Wu, Shijin Wang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 635-635
Open Access | Times Cited: 3
The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer
Zhen Ye, Jingru Yang, Hanming Jiang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 8
Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition
Sara Petillo, Cristina Capuano, Rosa Molfetta, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 9
Open Access | Times Cited: 18
Circular RNAs regulate parental gene expression: A new direction for molecular oncology research
Haicun Wang, Xin Gao, Shaobo Yu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
The Double-Edged Effects of MLN4924: Rethinking Anti-Cancer Drugs Targeting the Neddylation Pathway
Haoming Tang, Xin Pang, Shun Li, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 738-738
Open Access | Times Cited: 2
Succinate dehydrogenase deficiency-driven succinate accumulation induces drug resistance in acute myeloid leukemia via ubiquitin-cullin regulation
Yifan Chen, Miao Xian, Wen-wen Ying, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Neddylation pathway promotes myeloid-derived suppressor cell infiltration via NF-κB-mCXCL5 signaling in lung cancer
Lisha Zhou, Xiongzhi Lin, Luyi Zhang, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109329-109329
Open Access | Times Cited: 9
Discovery of neddylation E2s inhibitors with therapeutic activity
MAA Mamun, Ying Liu, Yin-Ping Geng, et al.
Oncogenesis (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Site-specific proteomic strategies to identify ubiquitin and SUMO modifications: Challenges and opportunities
Fredrik Trulsson, Alfred C.O. Vertegaal
Seminars in Cell and Developmental Biology (2021) Vol. 132, pp. 97-108
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top